Prediction of response to acute neuroleptic treatment in schizophrenia

International Clinical Psychopharmacology

Volumn 11, Issue SUPPL. 2, 1996, Pages 47-54

  Gaebel, W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Illness course; Neuroleptics; Outcome; Prediction; Response; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; PERAZINE;

CONFERENCE PAPER; DRUG EFFICACY; DRUG RESPONSE; HUMAN; PREDICTION; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0029949320     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199605002-00008     Document Type: Conference Paper

References (31)

1. Alpert M (1985) The signs and symptoms of schizophrenia. Compr Psychiatry 26:103-112.
2. AMP (1995) Das AMDP-System. Manual zur Dokumentation psychiatrischer Befunde. Gottingen: Hogrefe, Verlag fur Psychologie.
3. Awad AG (1989) Drug therapy in schizophrenia: variability of outcome and prediction of response. Can J Psychiatry 1989; 34:711-720.
4. Awad A (1992) Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Community Psychiatry 43:262-265.
5. Awad AG (1994) Prediction research of neuroleptic treatment outcome in schizophrenia: state of the art: 1978-1993. In Prediction of Neuroleptic Treatment Outcome in Schizophrenia. Concepts and Methods. Edited by Gaebel W, Awad AG. New York: Springer; pp 1-14.
6. Awad AG, Hogan TP (1985) Early treatment events and prediction of response to neuroleptics in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 9:585-588.
7. Bartko G, Herczeg I, Bekesy M (1987) Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement. J Clin Psychiatry 48:363-365.
8. Buchsbaum MS, Luu CT (1994) Prediction of clinical response to neuroleptics and positron emission tomography in schizophrenia. In Prediction of Neuroleptic Treatment Outcome in Schizophrenia. Concepts and Methods. Edited by Gaebel W, Awad AG. New York: Springer; pp 123-134.
9. Carpenter WT, Heinrichs DW, Hanlon TE (1981) Methodologic standards for treatment outcome research in schizophrenia. Am J Psychiatry 138:465-471.
10. Engel GL (1980) The clinical application of the biopsycho-social model. Am J Psychiatry 135:535-544.
11. Gaebel W (1989) Indikatoren und Prädiktoren schizophrener Krankheitsstadien und Verlaufsausgänge. Berlin: Habilitationsschrift, Medizinische Fakultät der Freien Universität.
12. Gaebel W (1993) The importance of non-biological factors in influencing the outcome of clinical trials. Br J Psychiatry 163 (suppl 22):44-50.
13. Gaebel W, Awad AG (eds) (1994a) Prediction of Neuroleptic Treatment Outcome in Schizophrenia. Concepts and Methods. New York: Springer.
14. Gaebel W, Awad AG (1994b) Prediction research in neuroleptic therapy: future directions. In Prediction of Neuroleptic Treatment Outcome in Schizophrenia. Concepts and Methods. Edited by Gaebel W, Awad AG. New York: Springer; pp 203-209.
15. Gaebel W, Renfordt E (eds) (1989) Objective methods for behavioral analysis in psychiatry and psychopharmacology: examples and concepts. Pharmacopsychiatry 22 (suppl I): 1-50.
16. Gaebel W, Pietzcker A, Ulrich G, Schley J, Müller-Oerlinghausen B (1988) Predictors of neuroleptic treatment response in acute schizophrenia. Pharmacopsychiatry 21:384-386.
17. Gaebel W, Müller-Oerlinghausen B, Schley J (1992) Early serum levels of neuroleptics do not predict therapeutic response in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 16:891-900.
18. Hyman SE, Nestler EJ (1993) The Molecular Foundations of Psychiatry. Washington, DC: American Psychiatric Press.
19. Kinon BJ, Kane JM, Johns C, et al. (1993) Treatment of neuroleptic-resistant schizophrenic relapse. Psychopharmacol Bull 29:309-314.
20. Köpeke W (1994) Design, methodological and statistical issues in prediction research of neuroleptic response. In Prediction of Neuroleptic Treatment Outcome in Schizophrenia. Concepts and Methods. Edited by Gaebel W, Awad AG. New York: Springer; pp 155-164.
21. May PRA, Van Putten T, Yale C, et al. (1976) Predicting individual responses to drug treatment in schizophrenia: a test dose model. J Nerv Ment Dis 162:177-183.
22. May PRA, Goldberg SC (1978) Prediction of schizophrenic patients' response to pharmacotherapy. In Psychopharmacology: A Generation of Progress. Edited by Lipton MA, Dimascio A, Killam KF. New York: Raven Press; pp 1135-1139.
23. May PRA, Van Putten T, Yale C (1980) Predicting outcome of antipsychotic drug treatment from early response. Am J Psychiatry 137:1088-1089.
24. Möller HJ, Kissling W, Zerssen von D (1983) Die prognostische Bedeutung des frühen Ansprechens schizophrener Patienten auf Neuroleptika für den weiteren stationären Behandlungsverlauf. Pharmacopsychiatry 16:46-49.
25. Nedopil N, Rüther E (1981) Initial improvement as predictor of outcome of neuroleptic treatment. Pharmacopsychiatry 14: 205-207.
26. Nuechterlein KH (1987) Vulnerability models for schizophrenia: State of the Art. In Search for the Causes of Schizophrenia. Edited by Hafner H, Gattaz WF, Janzarik W. Berlin: Springer; pp 297-316.
27. Pickar D (1988) Perspectives on a time-dependent model of neuroleptic action. Schizophr Bull 1988; 14:255-268.
28. Selbach H (1961) Über die vegetative Dynamik in der psychiatrischen Pharmakotherapie. Dtsch Med J 16:511-517.
29. Van Praag HM, Kahn RS, Asnis GM, et al. (1987) Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affect Disord 13:1-8.
30. Van Putten T, May PRA (1978) Subjective response as a predictor of outcome in pharmacotherapy. Arch Gen Psychiatry 35:477-480.
31. Woggon B, Baumann U (1983) Multimethodological approach in psychiatric predictor research. Pharmacopsychiatry 16: 175-178.